Stocks · News reference
8-K filing — DocGo Inc. (DCGO)
Filed: 2026-08-17 AccNo: 0001628280-26-057387 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Needham Reiterates Buy on DocGo, Maintains $3 Price Target
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
Transcript: DocGo Q2 2026 Earnings Conference Call
DocGo (NASDAQ:DCGO) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.